Award
National Cancer Institute 5R01CA251470-06
Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial
Recipient
Dana-Farber Cancer Institute, Boston, MA, United States
Award Amount
$705,440.00
Ceiling
$705,440.00
Awarded
April 07, 2025
Identifier
5R01CA251470-06
A NIH-funded phase III randomized controlled trial to assess yoga's effectiveness in treating chemotherapy-induced peripheral neuropathy pain and improving patient outcomes among cancer survivors.
Description
This project aims to evaluate the efficacy of yoga in reducing chemotherapy-induced peripheral neuropathy (CIPN) pain, improving sensory nerve recovery, and decreasing fall risk among cancer survivors with moderate to severe CIPN pain. A phase III randomized controlled trial with 268 participants will be conducted to assess the impact of an eight-week yoga intervention compared to education and usual care.